RALEIGH, N.C. & OKLAHOMA CITY--(BUSINESS WIRE)--Lumata Health, a technology-driven healthcare innovator empowering ophthalmology practices to enhance continuous care for those at risk of blindness from chronic eye diseases, today formally announced its Clinical Advisory Board (CAB). The esteemed group of five leading ophthalmologists will provide strategic guidance to further Lumata’s mission of reducing preventable blindness through its turnkey, patient-centered continuous care platform.
The CAB offers a unique perspective, delivering decades of expertise in treating the leading causes of vision loss and cutting-edge technological advances. The board is charged with playing a pivotal role in shaping Lumata Health’s clinical strategies and ensuring the company leads the industry at the forefront of eye care innovation.
“Our Clinical Advisory Board is comprised of some of the brightest minds in ophthalmology who channel their passion and studied perspectives on patient care and best practices, ensuring Lumata's patient support initiatives complement and enhance the clinical care provided by physicians,” said Landon Grace, CEO and co-founder of Lumata Health. “Their collective knowledge and experience offer invaluable insights as we continue to grow the number of patients we serve by over 200% year over year.”
The newly established CAB will prioritize enhancing Lumata's data-driven continuous care model, integrating the latest behavioral insights and clinical data to provide personalized, supportive care. This approach has already demonstrated an impact on improving patient adherence: a group of 100 patients enrolled in Lumata’s program for 9 months was projected to attend 72 more office visits per year compared to matched controls.
“Lumata Health fills an important missing link in closing the care adherence gap for millions of Americans at risk of blindness by truly serving as Care Coaches for patients, helping patients navigate appointments, medications, and being champions for their health, all driven behind-the-scenes by the latest technology, and always delivered with a human touch,” said Clinical Advisory Board Chair, Benjamin Kunz, MD, of Oregon Eye Consultants. “We’re all excited to advance this important mission to further enhance patient outcomes and expand access to Lumata’s life-changing services.”
Andrew McClellan, MD; Sumit P. Shah, MD, FACS, FASRS, NJ Retina; Murtaza Adam, MD, Colorado Retina Associates; and Swarup Swaminathan, MD, Bascom Palmer Eye Institute will also join the Lumata Health CAB.
Lumata Health’s continuous care program is reimbursable under Medicare’s Chronic Care Management billing codes and covered by secondary, supplement, or Medicare Advantage plans–often at no additional cost to patients. As a part of continuous care services, Lumata works with patients to help lower the cost of prescriptions, access transportation, understand their disease, ensure appointment adherence, and remove other barriers to care.
Lumata Health’s platform is currently trusted by more than 1,400 ophthalmologists at many of the largest eye care organizations in the U.S., supporting more than 25,000 patients with chronic eye diseases, including glaucoma, diabetic retinopathy, and macular degeneration.
Lumata Health has raised more than $14.8 million in non-dilutive and venture funding to date.
Follow Lumata Health on LinkedIn, X, and Facebook for the latest news and information.
About Lumata Health
Founded in 2017 by Dr. Stephen R. Fransen, an ophthalmologist with over 30 years of experience, Lumata Health now employs more than 180 licensed Care Coaches, data scientists, and executives and is dedicated to ending preventable blindness through a human-led, technology-driven care management platform. The company partners with physicians, payers, and health systems to provide tailored care management services that improve clinical outcomes while reducing clinic workloads. For more information about Lumata Health, visit lumatahealth.com.
